Global beta interferon market stands at US$ 3.6 billion in 2023 and is expected to reach a valuation of US$ 4.8 billion by 2033, expanding at a CAGR of 3% over the next ten years. Rising prevalence of chronic disorders across the world is primarily driving global demand for beta interferon drugs. The Beta Interferon market, a critical segment of the pharmaceutical industry, plays a pivotal...